Citadel Advisors’s Xenetic Biosciences XBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-17,289
| Closed | -$45.1K | – | 7124 |
|
|
2025
Q1 | $45.1K | Buy |
17,289
+3,909
| +29% | +$10.2K | ﹤0.01% | 5388 |
|
|
2024
Q4 | $53.9K | Buy |
+13,380
| New | +$53.9K | ﹤0.01% | 5437 |
|
|
2023
Q2 | – | Sell |
-1,637
| Closed | -$6.74K | – | 6563 |
|
|
2023
Q1 | $6.74K | Sell |
1,637
-1,620
| -50% | -$6.67K | ﹤0.01% | 5583 |
|
|
2022
Q4 | $9.31K | Buy |
+3,257
| New | +$9.31K | ﹤0.01% | 5694 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 7005 |
|
|
2022
Q1 | – | Sell |
-5,798
| Closed | -$75K | – | 7217 |
|
|
2021
Q4 | $75K | Buy |
+5,798
| New | +$75K | ﹤0.01% | 6033 |
|
|
2021
Q3 | – | Sell |
-5,121
| Closed | -$104K | – | 7183 |
|
|
2021
Q2 | $104K | Sell |
5,121
-4,079
| -44% | -$82.8K | ﹤0.01% | 5953 |
|
|
2021
Q1 | $201K | Buy |
+9,200
| New | +$201K | ﹤0.01% | 5412 |
|
|
2019
Q1 | – | Sell |
-115
| Closed | -$22K | – | 5093 |
|
|
2018
Q4 | $22K | Buy |
+115
| New | +$22K | ﹤0.01% | 4245 |
|
|
2018
Q2 | – | Sell |
-97
| Closed | -$25K | – | 4637 |
|
|
2018
Q1 | $25K | Buy |
+97
| New | +$25K | ﹤0.01% | 3846 |
|